Skip to main content
Fig. 6 | Translational Medicine Communications

Fig. 6

From: Safety and efficacy of autologous non-hematopoietic enriched stem cell nebulization in COVID-19 patients: a randomized clinical trial, Abu Dhabi 2020

Fig. 6

High-Resolution Computer Tomography Scans Images of a Patient’s Chest. Legend: Patient No. 4. Group A (peripheral blood non-hematopoietic enriched stem cell cocktail + standard care): Images a) Day of recruitment (April 1st). Images b) Four days after the first dose of stem cell treatment (April 13th, nebulization was initiated on April 9th, and the second dose was commenced on April 10th)

Back to article page

Translational Medicine Communications

ISSN: 2396-832X

Contact us